In our study, we identified a series of potential tumor antigens, including SREBF1, LUC7L3, LAMA5, PCGF3, HNRNPH1, KLC4, and OFD1, by systematically analyzing alternative splicing and mutation of genes in patients with HNSCC. Here, SREBF1 is linked to neoplasm.